Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of ECSP066623ApublicationCriticalpatent/ECSP066623A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
Esta invención se refiere a bencimidazol-O-glucósidos, benztriazol-O-glucósidos, y bencimidazolona-O-glucósidos sustituidos, composiciones que los contienen, y métodos de uso de los mismos, por ejemplo, para el tratamiento o la profilaxis de la diabetes y del síndrome X.This invention relates to benzimidazol-O-glycosides, benztriazol-O-glycosides, and substituted benzimidazolone-O-glycosides, compositions containing them, and methods of use thereof, for example, for the treatment or prophylaxis of diabetes. and of syndrome X.
ECSP0666232003-11-122006-06-08
BENCIMIDAZOL-, BENZTRIAZOL-, AND BENCIMIDAZOLONA-O-GLUCOSIDS REPLACED
ECSP066623A
(en)
Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
Compounds derived from substituted nicotinamide; pharmaceutical composition that includes them; use for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases.